Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

Informazioni relative al progetto

BE-SAFE

ID dell’accordo di sovvenzione: 101057123

DOI

10.3030/101057123

Data della firma CE 18 Maggio 2022

Data di avvio 1 Settembre 2022

Data di completamento 31 Agosto 2027

Finanziato da

• Health

Costo totale

€ 4 883 232,00

Contributo UE

€ 4 883 229,00

Coordinato da

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Websites, patent fillings, videos etc. (3)

Information material for the public

Comprehensive set of information material related to overuse of BSH for the public

BE-SAFE podcasts online

Collection of Podcasts files tackling key topics related BSH addressed health professionals and general public

Public website

Public website up and running to centralise BE-SAFE products

Documents, reports (3)

Clinical pathways and healthcare systems

Current key clinical pathways (or care trajectories) in relation to BSH reduction identified and described in the six participating European countries

Guidelines to reduce BSHs

Trustworthy guidelines to reduce BSHs published on MAGICapp website and BE-SAFE portal

Barriers and enablers to reduce BSHs

Report of the survey, presenting the barriers and enablers to discontinuing BSHs among patients, informal carers and health care professionals in the six European countries

Pubblicazioni

Peer reviewed articles (6)

Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis

Autori: Dena Zeraatkar, Sumanth Kumbargere Nagraj, Michael Ling, Tanvir Jassal, Sarah Kirsh, João Pedro Lima, Tyler Pitre, Rachel Couban, Muizz Hussain, Siri Seterelv, Stijn Van de Velde, Katarzyna Gustavsson, Adam Wichniak, Carole E Aubert, Antoine Christiaens, Anne Spinewine, Thomas Agoritsas
Pubblicato in: BMJ, Numero 389, 2025, ISSN 1756-1833
Editore: BMJ
DOI: 10.1136/BMJ-2024-081336

Development and validation of the medical attitudes towards deprescribing questionnaire: comment

Autori: Vladyslav Shapoval; Andrea M. Patey; Séverine Henrard; Anne Spinewine
Pubblicato in: Internal and Emergency Medicine, 2024, ISSN 1970-9366
Editore: SIMI
DOI: 10.1007/S11739-024-03675-8

Equipping physicians for benzodiazepine receptor agonists deprescription in older adults: theory-based development of the BE-SAFE intervention

Autori: François-Xavier Sibille, Joanna Salbert, Lucy Bolt, Vagioula Tsoutsi, Enrico Callegari, Olivia Dalleur, Tokandji Adda, Thomas Agoritsas, Thomas Berger, Carole E. Aubert, Dimitris Dikeos, Antoni Salvà, Begoña Pascual, Ramon Miralles, Torgeir Bruun Wyller, Andrea M. Patey, Jeremy M. Grimshaw, Adam Wichniak, Anne Spinewine, Marie de Saint Hubert
Pubblicato in: Research in Social and Administrative Pharmacy, Numero 21, 2025, ISSN 1551-7411
Editore: Elsevier BV
DOI: 10.1016/J.SAPHARM.2025.05.002

Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians

Autori: Vladyslav Shapoval, Marie de Saint Hubert, Perrine Evrard, François-Xavier Sibille, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Pinelopi Kollia, Antoni Salvà, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Pubblicato in: JAMA Network Open, Numero 8, 2025, ISSN 2574-3805
Editore: American Medical Association (AMA)
DOI: 10.1001/JAMANETWORKOPEN.2024.59883

Deprescribing benzodiazepine receptor agonists for insomnia in older adults

Autori: Antoine Christiaens, Carole E Aubert, Adam Wichniak, Antoni Salvà Casanovas, Anne Spinewine
Pubblicato in: The Lancet, Numero 402, 2023, ISSN 0140-6736
Editore: Elsevier BV
DOI: 10.1016/S0140-6736(23)01562-3

Barriers to and Enablers of Supporting Deprescribing Benzodiazepines in Older Adults: A Survey of European Nonphysician Healthcare Professionals

Autori: Vladyslav Shapoval, Perrine Evrard, François‐Xavier Sibille, María López‐Toribio, Olivia Dalleur, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Maria Ntafouli, Laura Fernández Maldonado, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Pubblicato in: Basic & Clinical Pharmacology & Toxicology, Numero 137, 2025, ISSN 1742-7835
Editore: Wiley
DOI: 10.1111/BCPT.70100

Other (1)

Guideline - BE-SAFE: Deprescription of benzodiazepine and sedative hypnotics (BSHs) in insomnia disorder

Autori: Thomas Agoritsas; Sumanth Kumbargere Nagraj; Enrico Callegari; Minna Johansson
Pubblicato in: 2023
Editore: MAGIC Evidence Ecosystem Foundation